Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Japanese MHLW grants priority review to Bayer's regorafenib NDA for colorectal cancer

Sep. 12, 2012

Critical Outcome Technologies takes steps toward IND filing of oral formulation

Sep. 12, 2012

First launch of Pixuvri carried out in European countries

Sep. 12, 2012

Sanofi presents novel PI3K-beta inhibitor with activity in PTEN-deficient tumors

Sep. 12, 2012

SNS01-T combined with bortezomib effective in mouse tumor model

Sep. 12, 2012

AEterna Zentaris presents promising in vivo data for AEZS-136

Sep. 12, 2012

Phase I/II trial of Astex's HSP 90 inhibitor begins

Sep. 10, 2012

SFJ and Pfizer sign agreement to codevelop treatment for advanced NSCLC

Sep. 10, 2012

PM-01183 receives positive opinion for orphan drug status in E.U.

Sep. 10, 2012

CSIR patents novel agents for cancer

Sep. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...